Prime Minister Narendra Modi visited vaccine-maker Bharat Biotech’s facility in Hyderabad and reviewed the development of indigenous COVID-19 vaccine candidate Covaxin. The Prime Minister spent more than an hour at the Bharat Biotech facility where he is understood to have had a discussion with the company executives on various aspects of the vaccine. Following the visit, he tweeted to congratulate the scientists for their progress in the trials so far. ‘Their team is closely working with ICMR to facilitate speedy progress’, Modi wrote in his tweet. Bharat Biotech is developing Covaxin in collaboration with the Indian Council of Medical Research.
VK Sasikala quits politics ahead of TN polls, urges AIDMK to stay united
India led the world in internet shutdowns in 2020: Report
West Bengal: EC tells petrol pumps to remove hoardings with PM's pic
Hardoi horror: Man beheads daughter, takes head to cops
'Where's Savarkar's Bharat Ratna?': Maha CM asks BJP to not teach Hindutva
Assam polls: meet underway at Amit Shah's residence to finalise seat-sharing
Power to administer new digital media rules not with states, UTs: Centre
Shadow war: Chinese hackers still actively targeting Indian port, US firm claims
Income Tax raids at properties of Anurag, Taapsee, NCP reacts
EAM Jaishankar to travel to Bangladesh on Thursday to prepare for PM Modi’s visit
BJP rejected, people want AAP: Arvind Kejriwal on MCD bypoll win
Bharat Biotech: Covaxin showed 81% efficacy in phase 3 trials
'Comical': BJP mocks Rahul Gandhi for remarks on RSS
Jalgaon horror: girls allegedly stripped, forced to dance in govt run hostel
President Ram Nath Kovind receives first dose of Covid-19 vaccine
Bulandshahr: Missing girl's body found in a pit, accused arrested
Government allows hospitals to administer Covid vaccine 24x7
Sex scandal hits Karnataka govt, minister quits after CD surfaces
SC rejects plea seeking sedition charge on Farooq Abdullah
Watch: Priyanka Gandhi tries hand at plucking tea leaves in Assam